The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Liver disease in Egypt: Hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors
Abstract
In Egypt, schistosomiasis was traditionally the most important public health problem and infection with Schistosoma mansoni the major cause of liver disease. From the 1950s until the 1980s, the Egyptian Ministry of Health (MOH) undertook large control campaigns using intravenous tartar emetic, the standard treatment for schistosomiasis, as community-wide therapy. This commendable effort to control a major health problem unfortunately established a very large reservoir of hepatitis C virus (HCV) in the country. By the mid-1980s, the effective oral drug, praziquantel, replaced tartar emetic as treatment for schistosomiasis in the entire country. This both reduced schistosomal transmission and disease and interrupted the “occult” HCV epidemic. It was evident when diagnostic serology became available in the 1990s that HCV had replaced schistosomiasis as the predominant cause of chronic liver disease. Epidemiological studies reported a high prevalence and incidence of HCV, particularly within families in rural areas endemic for schistosomiasis. Clinical studies showed 70% to 90% of patients with chronic hepatitis, cirrhosis, or hepatocellular carcinoma had HCV infections. Co-infections with schistosomiasis caused more severe liver disease than infection with HCV alone. Schistosomiasis was reported to cause an imbalance in HCV-specific T-cell responses leading to increased viral load, a higher probability of HCV chronicity, and more rapid progression of complications in co-infected persons. As complications of HCV usually occur after 20 years of infection, the peak impact of the Egyptian outbreak has not yet occurred. Efforts have been initiated by the Egyptian MOH to prevent new infections and complications of HCV in the estimated 6 million infected persons. (Hepatology 2006;43:915–922.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2011) · Hepatogastroenterology · doi:10.5754/hge11753 · Cited by 2,435
Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
Lechner, F., Wong, D. K. H., Dunbar, P. R., Chapman, R., Chung, R. T., Dohrenwend, P., Robbins, G., Phillips, R., Klenerman, P., & Walker, B. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.9.1499 · Cited by 1,269
Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection
Thimme, R., Oldach, D., Chang, K.-M., Steiger, C., Ray, S. C., & Chisari, F. V. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.1395 · Cited by 1,189
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
Frank, C., Mohamed, M. K., Strickland, G. T., Lavanchy, D., Arthur, R. R., Magder, L. S., Khoby, T. E., Abdel-Wahab, Y., Ohn, E. S. A., Anwar, W., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06527-7 · Cited by 1,131
Self-citationActor, J. K., Shirai, M., Kullberg, M. C., Buller, R. M., Sher, A., & Berzofsky, J. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.948 · Cited by 353
Drugs for the control of parasitic diseases: current status and development in schistosomiasis
Fenwick, A., Savioli, L., Engels, D., Robert Bergquist, N., & Todd, M. H. (2003) · Trends in Parasitology · doi:10.1016/j.pt.2003.09.005 · Cited by 299
Hepatitis C Virus Infection in A Community in the Nile Delta: Risk Factors for Seropositivity
Habib, M., Mohamed, M. K., Abdel-Aziz, F., Magder, L. S., Abdel-Hamid, M., Gamil, F., Madkour, S., Mikhail, N. N., Anwar, W., Strickland, T. G., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.20797 · Cited by 295
Self-citationHunter's Tropical Medicine and emerging infectious diseases
STRICKLAND, G. T. (2001) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652001000200018 · Cited by 269
Abdel-Aziz, F., Habib, M., Mohamed, M. K., Abdel-Hamid, M., Gamil, F., Madkour, S., Mikhail, N. N., Thomas, D., Fix, A. D., Strickland, T. G., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.8438 · Cited by 265
Self-citationInfection with Schistosoma mansoni alters Th1/Th2 cytokine responses to a non-parasite antigen
Kullberg, M. C., Pearce, E. J., Hieny, S. E., Sher, A., & Berzofsky, J. A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.10.3264 · Cited by 251
Cited by
Syndemics and the biosocial conception of health
Singer, M., Bulled, N., Ostrach, B., & Mendenhall, E. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30003-x · Cited by 1,491
Omata, M., Lesmana, L. A., Tateishi, R., Chen, P.-J., Lin, S.-M., Yoshida, H., Kudo, M., Lee, J. M., Choi, B. I., Poon, R. T. P., et al. (2010) · Hepatology International · doi:10.1007/s12072-010-9165-7 · Cited by 1,026
Global challenges in liver disease
Williams, R. (2006) · Hepatology · doi:10.1002/hep.21347 · Cited by 788
Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis
Gomaa, A. I., Khan, S. A., Toledano, M. B., Waked, I., & Taylor-Robinson, S. D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4300 · Cited by 700
Epidemiology of Hepatitis B and C Viruses: A Global Overview
Te, H. S., & Jensen, D. M. (2010) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.11.009 · Cited by 482
Cancer burden in Africa and opportunities for prevention
Jemal, A., Bray, F., Forman, D., O'Brien, M., Ferlay, J., Center, M., & Parkin, D. M. (2012) · Cancer · doi:10.1002/cncr.27410 · Cited by 462
The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis
Mohamoud, Y. A., Mumtaz, G. R., Riome, S., Miller, D., & Abu-Raddad, L. J. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-288 · Cited by 413
Hotez, P. J., Savioli, L., & Fenwick, A. (2012) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001475 · Cited by 366
De Sanjose, S., Benavente, Y., Vajdic, C. M., Engels, E. A., Morton, L. M., Bracci, P. M., Spinelli, J. J., Zheng, T., Zhang, Y., Franceschi, S., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.011 · Cited by 338
The contribution of mass drug administration to global health: past, present and future
Webster, J. P., Molyneux, D. H., Hotez, P. J., & Fenwick, A. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0434 · Cited by 307
Screening and Treatment Program to Eliminate Hepatitis C in Egypt
Waked, I., Esmat, G., Elsharkawy, A., El-Serafy, M., Abdel-Razek, W., Ghalab, R., Elshishiney, G., Salah, A., Abdel Megid, S., Kabil, K., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmsr1912628 · Cited by 282
Gryseels, B. (2012) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2012.03.004 · Cited by 280
Global control of hepatitis C: where challenge meets opportunity
Thomas, D. L. (2013) · Nature Medicine · doi:10.1038/nm.3184 · Cited by 280
Schistosomiasis: challenges for control, treatment and drug resistance
Fenwick, A., & Webster, J. P. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000247591.13671.6a · Cited by 254
Metadata
- Authors
- Strickland, T. G.
- Venue
- Hepatology
- Published
- 2006-05
- Volume
- 43
- Issue
- 5
- Pages
- 915-922
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2123456471
- Cited by
- 272
- References
- 37
- FWCI
- 8.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.